Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2011 | -325 Thousand USD | 59.95% |
| 2010 | -809 Thousand USD | -14.59% |
| 2009 | -691 Thousand USD | 47.08% |
| 2008 | -1.11 Million USD | 15.52% |
| 2007 | -1.16 Million USD | -511.2% |
| 2006 | -680 Thousand USD | -72.15% |
| 2005 | -2.1 Million USD | 246.86% |
| 2004 | -255 Thousand USD | 74.57% |
| 2003 | -3.25 Million USD | 50.98% |
| 2002 | -10.49 Million USD | 2.77% |
| 2001 | -8.61 Million USD | 13.18% |
| 2000 | -8.91 Million USD | -170.45% |
| 1999 | -4.28 Million USD | -32.0% |
| 1998 | -2.6 Million USD | 3.85% |
| 1997 | -2.5 Million USD | -136.36% |
| 1996 | -1.3 Million USD | -22.22% |
| 1995 | -900 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2011 FY | - USD | 59.95% |
| 2010 FY | - USD | -14.59% |
| 2009 Q1 | -155 Thousand USD | 43.01% |
| 2009 FY | - USD | 47.08% |
| 2008 FY | - USD | 15.52% |
| 2008 Q1 | -528 Thousand USD | 71.93% |
| 2008 Q4 | -272 Thousand USD | -145.05% |
| 2008 Q3 | -111 Thousand USD | 73.82% |
| 2008 Q2 | -424 Thousand USD | 19.7% |
| 2007 FY | - USD | -511.2% |
| 2007 Q4 | -1.88 Million USD | -1880.0% |
| 2007 Q2 | 539 Thousand USD | 377.84% |
| 2007 Q1 | -194 Thousand USD | -273.08% |
| 2007 Q3 | -95 Thousand USD | -117.63% |
| 2006 Q4 | -52 Thousand USD | 80.81% |
| 2006 Q2 | 360 Thousand USD | 285.57% |
| 2006 FY | - USD | -72.15% |
| 2006 Q1 | -194 Thousand USD | 50.64% |
| 2006 Q3 | -271 Thousand USD | -175.28% |
| 2005 Q4 | -393 Thousand USD | -15.93% |
| 2005 FY | - USD | 246.86% |
| 2005 Q2 | 2.44 Million USD | 849.69% |
| 2005 Q3 | -339 Thousand USD | -113.87% |
| 2005 Q1 | -326 Thousand USD | -253.05% |
| 2004 FY | - USD | 74.57% |
| 2004 Q4 | 213 Thousand USD | 132.62% |
| 2004 Q3 | -653 Thousand USD | -658.12% |
| 2004 Q2 | 117 Thousand USD | 136.68% |
| 2004 Q1 | -319 Thousand USD | 76.1% |
| 2003 Q1 | -580 Thousand USD | 68.51% |
| 2003 FY | - USD | 50.98% |
| 2003 Q4 | -987 Thousand USD | -234.59% |
| 2003 Q3 | -152 Thousand USD | 71.11% |
| 2003 Q2 | -1.54 Million USD | -138.1% |
| 2002 Q2 | -1.73 Million USD | 10.54% |
| 2002 Q3 | -3.23 Million USD | -17.04% |
| 2002 FY | - USD | 2.77% |
| 2002 Q4 | -3.59 Million USD | 9.08% |
| 2002 Q1 | -1.93 Million USD | 29.89% |
| 2001 Q4 | -2.79 Million USD | -15.38% |
| 2001 FY | - USD | 13.18% |
| 2001 Q3 | -2.39 Million USD | -178.46% |
| 2001 Q2 | -1.68 Million USD | 49.11% |
| 2001 Q1 | -1.71 Million USD | 52.36% |
| 2000 Q4 | -3.55 Million USD | -113.95% |
| 2000 FY | - USD | -170.45% |
| 2000 Q1 | -1.54 Million USD | 9.87% |
| 2000 Q2 | -1.97 Million USD | -46.3% |
| 2000 Q3 | -1.65 Million USD | 16.28% |
| 1999 Q1 | -800 Thousand USD | 33.33% |
| 1999 Q4 | -1.5 Million USD | -36.36% |
| 1999 Q2 | -886 Thousand USD | 100.0% |
| 1999 FY | - USD | -32.0% |
| 1999 Q3 | -1.24 Million USD | 0.0% |
| 1998 FY | - USD | 3.85% |
| 1998 Q4 | -1.2 Million USD | -140.0% |
| 1998 Q3 | -500 Thousand USD | -66.67% |
| 1998 Q2 | -300 Thousand USD | 25.0% |
| 1998 Q1 | -400 Thousand USD | 20.0% |
| 1997 Q1 | -800 Thousand USD | 83.33% |
| 1997 Q4 | -500 Thousand USD | 28.57% |
| 1997 Q3 | -700 Thousand USD | 12.5% |
| 1997 FY | - USD | -136.36% |
| 1997 Q2 | -800 Thousand USD | -700.0% |
| 1996 Q3 | -500 Thousand USD | -150.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 FY | - USD | -22.22% |
| 1996 Q2 | -500 Thousand USD | -300.0% |
| 1996 Q4 | -600 Thousand USD | -20.0% |
| 1995 Q4 | 100 Thousand USD | 107.69% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q3 | -1.3 Million USD | -1400.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 66.285% |
| Ansell Limited | 209.86 Million USD | 100.155% |
| Ansell Limited | 206.3 Million USD | 100.158% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 100.759% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 79.999% |
| Psykey, Inc. | -1.29 Million USD | 74.909% |
| ConvaTec Group Plc | 455.5 Million USD | 100.071% |
| ConvaTec Group Plc | 455.5 Million USD | 100.071% |
| Encision Inc. | -544.19 Thousand USD | 40.279% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -129.18% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -195.643% |
| Innovative MedTech Inc. | -7.67 Million USD | 95.765% |
| LifePoint, Inc. | -14.2 Million USD | 97.712% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 94.747% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -50.998% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 19.908% |
| SmileDirectClub, Inc. | -186.13 Million USD | 99.825% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.073% |
| SheerVision, Inc. | -110.53 Thousand USD | -194.035% |
| United Health Products, Inc. | -2.5 Million USD | 87.012% |
| Vasamed, Inc. | -4.57 Million USD | 92.895% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 85.624% |
| Yubo International Biotech Limited | -1.17 Million USD | 72.404% |